NDC 25357-026-01 - EPIOXA CROSS-LINKING
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 25357-026
- Requested NDC
- 25357-026-01
- Package NDCs from labels
- 25357-026-01
- Manufacturer
- Glaukos Corporation
- Effective date
- 2025-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EPIOXA CROSS-LINKING - Glaukos Corporation | Glaukos Corporation | 2025-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 25357-026-01 | EPIOXA CROSS-LINKING | 1 in 1 POUCH | SOLUTION/ DROPS | 2.39 mg in 1mL | 3 | |
| 25357-026-01 | EPIOXA CROSS-LINKING | 2 mL in 1 SYRINGE, GLASS | SOLUTION/ DROPS | 2 mL | 2.39 mg in 1mL | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPIOXA CROSS-LINKING | RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC | Glaukos Corporation | 13cefc46-337c-41a3-b113-106bfe553bbb | 2025-11-18 | Warnings, Adverse reactions | NDA219910 25357-026-01 25357-024-01 25357-027-01 25357-024 25357002601 2727373 2727374 2727371 2727363 2727368 2727375 d8f31876-b83b-4535-b2c2-d66210c14b15 13cefc46-337c-41a3-b113-106bfe553bbb |
| Cobalefol | VITAMIN | V2 Pharma LLC | 7d409065-112d-4bc7-bae6-d558aeb7c0e4 | 2025-05-16 | Warnings | 7N464URE7E |